A LC–MS-based plasma protein panel (N = 192, Mean age: 75.8 ± 7.3 years) in the ADNI cohort observed a significant decrease in plasma ApoC1 levels in MCI and AD male patients without a significant change in the female group [105]. Here, APOC1 is linked to Alzheimer disease.